Your browser doesn't support javascript.
loading
Developing a mechanism-based therapy for acute psychiatric inpatients with psychotic symptoms: an Intervention Mapping approach.
Gussmann, Eva; Lucae, Susanne; Falkai, Peter; Padberg, Frank; Egli, Samy; Kopf-Beck, Johannes.
Afiliación
  • Gussmann E; Max Planck Institute of Psychiatry, Munich, Germany.
  • Lucae S; Max Planck Institute of Psychiatry, Munich, Germany.
  • Falkai P; Department of Psychiatry and Psychotherapy, LMU University Hospital Munich, Munich, Germany.
  • Padberg F; Max Planck Institute of Psychiatry, Munich, Germany.
  • Egli S; Department of Psychiatry and Psychotherapy, LMU University Hospital Munich, Munich, Germany.
  • Kopf-Beck J; Department of Psychiatry and Psychotherapy, LMU University Hospital Munich, Munich, Germany.
Front Psychiatry ; 14: 1160075, 2023.
Article en En | MEDLINE | ID: mdl-37324820
ABSTRACT

Background:

Treatment guidelines for psychosis recommend offering psychotherapy already in the acute illness phase. However, there is a lack of available interventions adapted to the specific needs and key change mechanisms of inpatients experiencing severe symptoms and crisis. In this article we outline the scientific development process of a needs-oriented and mechanism-based group intervention for acute psychiatric inpatients with psychosis (MEBASp).

Methods:

To guide our intervention design, we used Intervention Mapping (IM), a six-step framework for developing evidence-based health interventions that consisted of an extensive literature review, an in-depth problem definition and needs analysis, the modeling of change mechanisms and outcomes and the production of an intervention prototype.

Results:

Our low-threshold modularized group intervention consists of nine stand-alone sessions (two per week) within three modules and targets different aspects of metacognitive and social change mechanisms. Module I and II aim to reduce acute symptoms by fostering cognitive insight, Module III focuses on reducing distress via cognitive defusion. Therapy contents are adapted from existing metacognitive treatments such as the Metacognitive Training and presented in a destigmatizing, simply understandable and experience-oriented way.

Conclusion:

MEBASp is currently evaluated in a single-arm feasibility trial. Using a systematic and rigorous development methodology and providing a detailed description of the development steps demonstrated to be invaluable in improving the intervention's scientific foundation, validity, and replicability for similar research.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Guideline Idioma: En Revista: Front Psychiatry Año: 2023 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Guideline Idioma: En Revista: Front Psychiatry Año: 2023 Tipo del documento: Article País de afiliación: Alemania